Cargando…
Improving safety of the continual reassessment method via a modified allocation rule
This article proposes a novel criterion for the allocation of patients in phase I dose‐escalation clinical trials, aiming to find the maximum tolerated dose (MTD). Conventionally, using a model‐based approach, the next patient is allocated to the dose with the toxicity estimate closest (in terms of...
Autores principales: | Mozgunov, Pavel, Jaki, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064916/ https://www.ncbi.nlm.nih.gov/pubmed/31859399 http://dx.doi.org/10.1002/sim.8450 |
Ejemplares similares
-
Practical implementation of the partial ordering continual reassessment method in a Phase I combination‐schedule dose‐finding trial
por: Mozgunov, Pavel, et al.
Publicado: (2022) -
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
por: Mozgunov, Pavel, et al.
Publicado: (2019) -
An information theoretic phase I–II design for molecularly targeted agents that does not require an assumption of monotonicity
por: Mozgunov, Pavel, et al.
Publicado: (2018) -
An order restricted multi‐arm multi‐stage clinical trial design
por: Serra, Alessandra, et al.
Publicado: (2022) -
How to design a dose-finding study using the continual reassessment method
por: Wheeler, Graham M., et al.
Publicado: (2019)